![]() Immunology & Immunological Disorders Poster Session |
Results
OK-PSA (0 to 1.0 mg/ml) was added into the PBMC culture. Twenty-four h later, cytokines in the supernatants and NK, LAK activities of the PBMC were measured. As shown in Fig.1A and B, The production of IFN-g, TNF-a, and -b (Th1 cytokines) as well as IL-12 (Th1-inducer) by PBMC was significantly increased addition of OK-PSA. IL-2 was not detected in the supernatant derived from the PBMC culture stimulated with OK-PSA. In Th2 cytokines, OK-PSA treatment accelerated only IL-6 production, but not IL-4 or IL-10 (Fig. 2C). Furthermore, the treatment with OK-PSA significantly accelerated both NK and LAK activities of PBMC in a dose dependent manner as compared with untreated controls (Fig. 1D).
We concerned the time course of the expression of mRNAs for cytokines using semiquantitative RT-PCR method. In all of the cytokines tested, mRNA expression were increased within 6 h after OK-PSA stimulation. The expression of the mRNAs encoding IL-2, IL-10, IL-12p35 and p40 was decreased over 24 h after OK-PSA stimulation, whereas mRNA expression for IFN-g, TNF-a, -b and IL-6 showed almost same levels from 6 to 48 h after stimulation (Fig. 2A, B and C). In additioon, mRNA expression of Fas ligand was also enhanced from 12 h after stimulation (Fig. 2D). The expression of GAPDH mRNA, used as an internal control, was approximately the same in all times after stimulation.
To clarify the subpopulations which elicits cytokine-inducing activity after the stimulation of OK-PSA, PBMC were fractionated to monocytes, CD4+T, CD8+T and NK cells. Isolated monocytes, CD4+T, CD8+T and NK cells were 89, 94, 94 and 96% pure, respectively, after subsequent analysis by FACS. Cells (1 x 105) of each fraction separated were cultured for 24 h with OK-PSA (0.1 mg/ml), then the supernatants were assayed for cytokines. Although NK cells stimulated by OK-PSA produced IFN-g both in the presence and in the absence of monocytes, the secretion of IFN-g by CD4+ and CD8+T cells was limited in the presence of monocytes (Fig. 3A and B). TNF-a were produced by monocytes or by lymphocytes cocultured with monocytes (Fig. 3C). Although TNF-b were secreted by T and NK cells, TNF-b secretion by T cells was accelerated in the presence of monocytes (Fig. 3D).
As described above, only few amounts of IL-10 were induced by OK-PSA (Fig. 1C). As shown in Fig. 4A, PBMC treated with OK-432 for 24 h secreted large amounts of IL-10. Moreover, streptococcal M-protein, one of the components of OK-432, is reportedly suggesed to play an important role for cytokine induction. We hypothesized that the molecule which plays a main role on IL-10 inducing activity of OK-432, may be streptococcal M-protein but not OK-PSA, and examined IL-10 inducing activity of streptococcal M-protein. Data were shown in Fig. 4B. Streptococcal M-protein demonstrated significant IL-10 inducing activity on PBMC as compared with untreated control. To evaluate the effect of IL-6 and IL-10 on IFN-g production and cytolytic activities of PBMC in vitro, we added anti-IL-6 and anti-IL-10 neutralizing antibodies as well as rIL-10 into the PBMC culture in the presence or absence of OK-PSA, then IFN-g in the supernatants and NK, LAK activities of PBMC were analysed. Addition of rIL-10 significantly inhibited IFN-g-inducing activity of OK-PSA (Fig. 5A). Recombinant IL-10 as well as anti-IL-6 antibody significantly decreased both NK and LAK activities augmented by the treatment with OK-PSA as compared with respective controls. Furthermore, NK and LAK activities of the PBMC stimulated with OK-PSA were slightly but significantly increased by addition of anti-IL-10 neutralizing antibodies (Fig. 5B and C).
Figure 5. Effect of anti-IL-6 and anti-IL-10 neutralizing antibodies as well as rIL-10 on IFN-g, NK and LAK activities induced by OK-PSA
| Discussion Board | Next Page | Your Poster Session | |
||||||||||
Okamoto, M.; Goda, H.; Ohe, G.; Yoshida, H.; Sato, M.; (1998). Induction of Th1-type cytokines in vitro by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal preparation.. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/immunology/okamoto0234/index.html | |||||||||||
© 1998 Author(s) Hold Copyright |